Publications by authors named "S R Soerensen"
Background: Prevention is a cornerstone for management of recurrent urinary stone disease. Current guidelines recommend metabolic evaluation, lifestyle modification, and medical treatment for patients with urinary stone disease. Nephrologists are uniquely qualified to evaluate stone risk and formulate treatment strategies to reduce that risk.
View Article and Find Full Text PDFArticle Synopsis
- Prostate cancer is the most prevalent cancer among men in the U.S., and this study explores the link between pesticide exposure and its incidence and mortality.
- Researchers analyzed the relationship between the use of 295 pesticides and prostate cancer rates using county-level data from two different cohorts spanning multiple years.
- They found consistent associations for 22 pesticides with prostate cancer incidence, with four also linked to mortality, suggesting a need for further investigation into these pesticides' potential health impacts.
Objective: To determine rates of urology follow-up and implementation of stone prevention measures after stone surgery and to assess variation in care delivery within a large, integrated healthcare system.
Materials And Methods: We used nationwide data from the United States Veterans Health Administration to identify patients who had stone surgery between 2016 and 2018 and who were at higher risk for recurrence. Our cohort included 13,444 Veterans across 90 facilities.
Purpose: Patients treated with radical cystectomy experience a high rate of postoperative complications and frequent hospital readmissions. We sought to explore the utility of the Care Assessment Need (CAN) score, derived from electronic health data, to estimate the risk of these adverse clinical outcomes, thereby aiding patient counseling and informed treatment decision-making.
Materials And Methods: We retrospectively examined data from 982 patients with bladder cancer who underwent radical cystectomy between 2013 and 2018 within the national Veterans Health Administration system.
Trends in pre-biopsy MRI usage for prostate cancer detection, 2007-2022.
Prostate Cancer Prostatic Dis
September 2024
Background: Clinical guidelines favor MRI before prostate biopsy due to proven benefits. However, adoption patterns across the US are unclear.
Methods: This study used the Merative™ Marketscan® Commercial & Medicare Databases to analyze 872,829 prostate biopsies in 726,663 men from 2007-2022.